Adoptive immunotherapy for stage IV renal cell carcinoma: a novel protocol utilizing periodate and interleukin-2-activated autologous leukocytes and continuous infusions of low-dose interleukin-2.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples